Transfection, defined as functional delivery of cell-internalized nucleic acids, is dependent on many factors linked to formulation, vector, cell type, and microenvironmental culture conditions. We previously developed a technology termed glycosaminoglycan (GAG)-binding enhanced transduction (GET) to efficiently deliver a variety of cargoes intracellularly, using GAG-binding peptides and cell penetrating peptides (CPPs) in the form of nanoparticles, using conventional cell culture. Herein, we demonstrate that the most simple GET transfection formulation (employing the FLR peptide) is relatively poor at transfecting cells at increasingly lower dosages. However, with an endosomally escaping version (FLR:FLH peptide formulations) we demonstrat...
Nanotechnologies are being increasingly applied as systems for peptide and nucleic acid macromolecul...
Protein therapy holds great promise for treating a variety of diseases. To act on intracellular targ...
The hydrophobic nature of cell membranes is one of the major obstacles in the therapeutic delivery o...
Transfection, defined as functional delivery of cell-internalized nucleic acids, is dependent on man...
Controlled release systems for therapeutic molecules are vital to allow the sustained local delivery...
Controlled release systems for therapeutic molecules are vital to allow the sustained local delivery...
The efficient delivery of DNA is of great importance for therapeutic applications such as gene thera...
Protein transduction domains (PTDs) are powerful nongenetic tools that allow intracellular delivery ...
Physical-based gene delivery via biolistic methods (such as the Helios gene gun) involve precipitati...
Gene therapy holds the promise of revolutionizing the way we treat diseases. By using recombinant DN...
Gene therapy has recently come of age with seven viral vector-based therapies gaining regulatory app...
Despite their success as gene therapy delivery systems, viral vectors have some unresolved issues; p...
The lung remains an attractive target for the gene therapy of monogenetic diseases such as cystic fi...
Many viral and nonviral systems have been developed to aid delivery of biologically active molecules...
Nanotechnologies are being increasingly applied as systems for peptide and nucleic acid macromolecul...
Protein therapy holds great promise for treating a variety of diseases. To act on intracellular targ...
The hydrophobic nature of cell membranes is one of the major obstacles in the therapeutic delivery o...
Transfection, defined as functional delivery of cell-internalized nucleic acids, is dependent on man...
Controlled release systems for therapeutic molecules are vital to allow the sustained local delivery...
Controlled release systems for therapeutic molecules are vital to allow the sustained local delivery...
The efficient delivery of DNA is of great importance for therapeutic applications such as gene thera...
Protein transduction domains (PTDs) are powerful nongenetic tools that allow intracellular delivery ...
Physical-based gene delivery via biolistic methods (such as the Helios gene gun) involve precipitati...
Gene therapy holds the promise of revolutionizing the way we treat diseases. By using recombinant DN...
Gene therapy has recently come of age with seven viral vector-based therapies gaining regulatory app...
Despite their success as gene therapy delivery systems, viral vectors have some unresolved issues; p...
The lung remains an attractive target for the gene therapy of monogenetic diseases such as cystic fi...
Many viral and nonviral systems have been developed to aid delivery of biologically active molecules...
Nanotechnologies are being increasingly applied as systems for peptide and nucleic acid macromolecul...
Protein therapy holds great promise for treating a variety of diseases. To act on intracellular targ...
The hydrophobic nature of cell membranes is one of the major obstacles in the therapeutic delivery o...